Analystreport

Leap Therapeutics (NASDAQ:LPTX) is now covered by analysts at Weiss Ratings. They set a "sell (e+)" rating on the stock.

Leap Therapeutics, Inc.  (LPTX) 
Last leap therapeutics, inc. earnings: 11/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.leaptx.com